Gary Nabors
Corporate Officer/Principal en APPILI THERAPEUTICS INC. .
Perfil
Gary S.
Nabors currently works at DynPort Vaccine Co. LLC, as President and Appili Therapeutics, Inc., as Chief Development Officer from 2023.
Dr. Nabors also formerly worked at Biotherapeutics, Inc., as Chief Development Officer & Executive VP.
Cargos activos de Gary Nabors
Empresas | Cargo | Inicio |
---|---|---|
APPILI THERAPEUTICS INC. | Corporate Officer/Principal | 03/04/2023 |
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | President | - |
Antiguos cargos conocidos de Gary Nabors.
Empresas | Cargo | Fin |
---|---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
APPILI THERAPEUTICS INC. | Health Technology |
Empresas privadas | 2 |
---|---|
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | Commercial Services |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
- Bolsa de valores
- Insiders
- Gary Nabors